Arecoline hydrobromide
Arecoline hydrobromide is a nicotinic acids-based alkaloid and partial agonist of muscarinic acetylchiline M1, M2, M3 and M4 receptors. The LD50 of subcutaneous injection value is 100 mg/kg in mouse [1].
Arecoline hydrobromide has been suggested to have electrophysiological effects on ventricular myocytes. Arecoline hydrobromide has shown the significant inhibitory effect on hERG current with the IC50 value of 9.55μmol/L. Furthermore, Arecoline hydrobromide has demonstrated the concentration- , time- and voltage-dependent characteristics of IhERG inhibition in the patch clamp experiments. Apart from these, Arecoline hydrobromide has been exhibited to significant change in the amount of steady-state blockade at stimulation frequencies. It has been shown frequency-dependent characteristics inhibition of IhERG by Arecoline hydrobromide [1].
References:
[1] Zhao XY1, Liu YQ, Fu YC, Xu B, Gao JL, Zheng XQ, Lin M, Chen MY, Li Y. Frequency- and state-dependent blockade of human ether-a-go-go-related gene K+ channel by arecoline hydrobromide. Chin Med J (Engl). 2012 Mar;125(6):1068-75.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 236.11 |
| Cas No. | 300-08-3 |
| Formula | C8H14BrNO2 |
| Solubility | ≥11.81 mg/mL in DMSO; ≥2.73 mg/mL in EtOH with gentle warming and ultrasonic; ≥59.1 mg/mL in H2O |
| Chemical Name | methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate;hydrobromide |
| SDF | Download SDF |
| Canonical SMILES | CN1CCC=C(C1)C(=O)OC.Br |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
